"Designing Growth Strategies is in our DNA"

Endoscopic Closure Systems Market Size, Share, and Industry Analysis, By Type (Overstitch Endoscopic Suturing System (OTSS), Over-the-Scope Clips (OTSC), Through-the-Scope Clip (TTSC), and Others), By Application (Gastrointestinal Surgeries, Cardiothoracic Surgeries, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast till 2032

Region : Global | Report ID: FBI111654 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global endoscopic closure systems market is witnessing significant growth due to their increasing adoption influenced by a combination of factors such as the shift toward minimally invasive surgeries, increasing prevalence of gastrointestinal diseases, technological advancements, and improvements in healthcare infrastructure. These factors collectively are increasing the demand for ECS as a preferred solution in modern surgical practices, which is expected to fuel the market growth.

  • For instance, in September 2021, the World Journal of Gastrointestinal Surgery stated that minimally invasive surgery (MIS) is becoming more popular for gastrointestinal (GI) tract procedures due to its benefits over traditional open surgery. This is expected to boost the demand for endoscopic closure systems, driving the market growth during the forecast period.

Endoscopic Closure Systems Market Driver

Rising Incidence of Gastrointestinal Diseases to Boost Market Growth

The surging incidence of gastrointestinal (GI) diseases is a significant factor propelling the adoption of endoscopic closure systems (ECS). Chronic GI diseases contribute to several complications annually, emphasizing the need for effective treatment options such as ECS. The demand for ECS is particularly high due to the rising cases of GI perforations and leaks, which necessitate efficient closure methods to prevent complications. Such a scenario is projected to boost the market growth.

  • For instance, according to data published by Cleveland Clinic in September 2023, around 5.0% of the U.S. population is projected to be affected by acute appendicitis in their lifetime. Such a high incidence of this disease leading to gastrointestinal (GI) perforation is anticipated to spur the demand for endoscopic closure systems, driving the market expansion.

Download Free sample to learn more about this report.

According to data published by the Endoscopy Campus, colonoscopy accounted for the highest number of total endoscopic procedures in 2021. In some cases, endoscopy can cause a perforation, which is a tear in the lining of the stomach, esophagus, or duodenum, which may lead to serious complications.

Endoscopic Closure Systems Market Restraint

High Costs of Endoscopic Closure Systems (ECS) May Hamper Market Growth

In some countries, the cost of endoscopic closure systems is notably high, which may pose challenges for their widespread adoption and utilization in clinical settings. In addition to the equipment costs, there are significant expenses related to training healthcare professionals to effectively use these advanced systems, which may limit their adoption, hampering the market growth.

  • For instance, as per the International Journal of Gastrointestinal Intervention in July 2019, the cost of the over-the-scope clip (OTSC) device kit ranges from USD 438.0 to USD 610.0, while traditional TTS clips are priced between USD 150.0 and USD 200.0 in the U.S. This initial investment can deter healthcare facilities, especially those operating on tight budgets, thereby hampering the market growth.

Endoscopic Closure Systems Market Opportunity

Advancements in Endoscopic Closure Systems May Spur Market Expansion

Innovations in endoscopic closure techniques are improving the precision and effectiveness of ECS, making them more appealing to healthcare providers. This is expected to offer a significant opportunity for key players to develop a novel endoscopic closure system based on this novel technique, thereby contributing to market expansion in the near future.

  • For instance, according to the Journal of Gastrointestinal Endoscopy, in February 2024, researchers developed a novel endoscopic closure technique, "internal traction–assisted suspended closure," for GI defect closure. Such innovations are expected to support new product launches in the coming years, contributing to market expansion.

Segmentation

By Type

By Application

By End-user

By Geography

  • Overstitch Endoscopic Suturing System (OTSS)
  • Over-the-Scope Clips (OTSC)
  • Through-the-Scope Clip (TTSC)
  • Others
  • Gastrointestinal Surgeries
  • Cardiothoracic Surgeries
  • Others
  • Hospitals & ASCs
  • Specialty Clinics
  • Others

· North America (U.S. and Canada)

· Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

· Latin America (Brazil, Mexico, and the Rest of Latin America)

· Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Number of Key Surgeries, By Key Countries/Regions, 2023
  • Key Industry Developments (Mergers, Acquisitions, and Partnerships)
  • New Product Launches/Approvals, By Key Players
  • Overview: Technological Advancements in Endoscopic Closure Systems
  • Impact of COVID-19 on the Market

Analysis by Type

Based on type, the market is fragmented into overstitch endoscopic suturing system (OTSS), over-the-scope clips (OTSC), through-the-scope clip (TTSC), and others.

The overstitch endoscopic suturing system (OTSS) segment is expected to hold a substantial share of the global market. The segment growth can be attributed to the increasing number of regulatory approvals for such devices, which is expected to increase its availability in the global market. Moreover, the growing acquisitions among the prominent players for endoscopic surgery products, including overstitch endoscopic suturing systems (OTSS), are also expected to fuel segment growth.

  • For instance, in November 2022, Boston Scientific Corporation acquired Apollo Endosurgery, Inc., a provider of overstitch endoscopic suturing systems (OTSS), supporting endoluminal surgery (ELS) procedures by the closure of gastrointestinal defects. Such strategic initiatives by prominent players are anticipated to boost the segment growth.

Analysis by Application

On the basis of application, the market is segmented into gastrointestinal surgeries, cardiothoracic surgeries, and others.

The gastrointestinal surgeries segment is expected to hold a major share of the global market during the forecast period. The segment growth can be attributed to the high significance of endoscopic closure systems in gastrointestinal surgeries. Moreover, the growth in GI surgeries is mainly driven by the increasing prevalence of GI disorders, which is projected to fuel the segment growth.

  • For instance, an article published by Jaypee Hospital in August 2023 stated that there has been a significant rise in the prevalence of GI diseases in recent years, which has raised concerns regarding the public's health. Such a scenario may increase the volume of GI surgeries, driving the demand for endoscopic closure systems and propelling the segment growth.

Analysis by End-user

By end-user, the market is fragmented into hospitals & ASCs, specialty clinics, and others.

The specialty clinics segment is projected to expand at a substantial CAGR during the projection period. The growth is mainly attributed to the increasing number of GI providers globally, which is anticipated to contribute to the large number of GI surgeries, increasing the adoption of endoscopic closure systems.

  • For instance, according to the study published by NCBI in August 2022, the number of gastroenterology physicians increased from 12,766 to 13,934 between 2012 and 2020. Such growth in the number of physicians is projected to boost the demand for endoscopic closure systems, propelling the segment growth.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the global endoscopic closure systems market in 2023. The regional growth is attributed to the growing number of endoscopy procedures in the U.S., which may spur the demand for endoscopic closure systems, supporting regional market expansion.

  • For instance, according to the Journal of Techniques and Innovations in Gastrointestinal Endoscopy (TIGE), in 2021, over 18.0 million endoscopy procedures were performed annually in the U.S., which may lead to high utilization of endoscopic closure systems.

Europe is the second-largest market based on the demand for endoscopic closure systems treatment products. The growth is attributable to the established healthcare infrastructure in the region, which may attract several key players to market their products in the region.

The Asia Pacific is expected to grow at the highest CAGR during the forecast period. The regional growth can be attributed to the high burden of GI disorders that are spurring the volume of various endoscopic procedures involving the use of endoscopic closure systems. Moreover, this surge in GI complications and procedures is mainly influenced by the aging population in the region.

  • For instance, according to data published by the World Economic Forum in September 2023, more than 1 in 10 individuals in Japan are currently aged 80 or older, and a third of its population is over 65 who are at high risk of developing GI conditions. This is anticipated to boost the regional market growth over the coming years.

Key Players Covered

The global endoscopic closure systems market is consolidated, with many companies offering various treatment products.

The report includes the profiles of the following key players:

  • Boston Scientific Corporation (U.S.)
  • Ovesco Endoscopy AG (Germany)
  • CooperSurgical Inc. (U.S.)
  • STERIS (U.S.)
  • Cook (U.S.)
  • Duomed Group (Denmark)
  • Medtronic (U.S.)
  • Micro-Tech Endoscopy (China)
  • Changzhou JIUHONG Medical Instrument Co., Ltd. (China)
  • Abbott (U.S.)

Key Industry Developments

  • In January 2022, Cook launched Instinct Plus, an endoscopic clipping device, making it commercially available to U.S. physicians for defect closure, anchoring procedures, and prophylactic clipping in the GI tract.
  • In July 2020, Olympus Corporation announced the commercial availability of its 510(k) cleared EZ Clip endo-therapy device for bleeding control and defect closure during GI endoscopy procedures.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann